Impact of the COVID‑19 pandemic on acute pancreatitis in the Czech Republic: pilot data from the PANACOTA (pancreatitisacuta in COVID time analysis) study

HARAZIM, Martin and Radek KROUPA. Impact of the COVID‑19 pandemic on acute pancreatitis in the Czech Republic: pilot data from the PANACOTA (pancreatitisacuta in COVID time analysis) study. In 42nd International Symposium on Intensive Care & Emergency Medicine. 2023.

Basic information

• Original name: Impact of the COVID‑19 pandemic on acute pancreatitis in the Czech Republic: pilot data from the PANACOTA (pancreatitisacuta in COVID time analysis) study
• Authors: HARAZIM, Martin and Radek KROUPA.
• Edition: 42nd International Symposium on Intensive Care & Emergency Medicine, 2023.

Other information

• Original language: English
• Type of outcome: Conference abstract
• Field of Study: 30219 Gastroenterology and hepatology
• Country of publisher: Belgium
• Confidentiality degree: is not subject to a state or trade secret
• Organization unit: Faculty of Medicine
• Keywords in English: acute pancreatitis; COVID-19; surgery; endoscopic drainage; complications; epidemiology

Abstract

healthcare. Acute pancreatitis (AP) is a clinically serious disease that almost always requires hospitalisation and treatment that cannot be delayed or planned. International studies have highlighted the potential negative impact of COVID-19 infection on the onset and severity of the disease. The aim of this study is to analyse the impact of the COVID-19 pandemic on the epidemiology, treatment and prognosis of acute pancreatitis at the population level. Methods: Comparison of parameters of hospitalizations for acute pancreatitis, care provided and treatment outcomes during the pandemic (2020 + 2021) with previous years (2010–2019) using data from the National Registry of Covered Health Services. Presentation of pilot data. Results: Hospitalizations for AP increased slightly from 2010 to 2015 to about 7000/year with a relatively stationary number in 2016– 2021. Hospitalizations for AP in each month of 2020 and 2021 did not correlate with the number of COVID-19 positive patients and showed a similar trend (with peaks in summer and at the end of the year) as in the years prior to the pandemic. Concurrently with AP, 2.3% and 3.7% of patients had COVID-19 infection in 2020 and 2021, respectively. AP mortality in the pre-pandemic and pandemic years was virtually the same at 3.9%. There was no difference in length of hospital or ICU stay. There was a downward trend in the number of ERCPs and surgical interventions performed. Conclusions: According to pilot population data, the COVID-19 pandemic did not have an impact on the incidence or prognosis of acute pancreatitis in the Czech Republic. Changes in trends in interventions performed correlate with recent expert recommendations and are unlikely to be related to the reduction in care due to the pandemic.